Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-04 22:01:25 - browse：6459

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Florida health officials providing scant details on measles cases

WSS

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Change Healthcare: What is it, why does its cyberattack matter?

3 trends to watch in health tech's hiring outlook for 2024

Pregnant women don't need prenatal multivitamins, study concludes

$1 billion proposal to grow Boston, Massachusetts biotech

Ancient Greek ideas underpin modern concepts of pregnancy

entertainment

Wikipedia

hotspot

What does generative AI mean for health care? We asked experts

IVF doctors demand details after CooperSurgical lawsuit

The cancer drug shortage isn’t new — and neither are the solutions

For AI in health care standards, federal regulators join with industry group

Alkermes shareholders re

State of the Union pitch: Bigger Medicare drug price negotiations

Virginia high school admissions case could be legal follow

The untold story of TV’s first prescription drug ad

Virginia high school admissions case could be legal follow

How a scoliosis diagnosis changed the life of one young dancer

knowledge

First over

Feng Zhang CRISPR delivery startup lays off quarter of staff

The FDA must approve intranasal treatments for anaphylaxis